Literature DB >> 11545688

Identical mutations in NOG can cause either tarsal/carpal coalition syndrome or proximal symphalangism.

M E Dixon1, P Armstrong, D B Stevens, M Bamshad.   

Abstract

PURPOSE: To identify the gene causing tarsal/carpal coalition syndrome (TCC).
METHODS: Individuals from three kindreds with TCC and normal hearing were used to map TCC and screen for mutations in Noggin (NOG).
RESULTS: Three different missense mutations in NOG were found. Two of these mutations are identical to mutations previously reported to cause proximal symphalangism (SYM1).
CONCLUSIONS: TCC is allelic to SYM1, and at least two different mutations in NOG can result in either TCC or SYM1 in different families. This finding suggests that phenotypic differences between these conditions are caused by epistatic modifiers of NOG.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545688     DOI: 10.1097/00125817-200109000-00004

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  17 in total

1.  Identification of two novel mutations in the NOG gene associated with congenital stapes ankylosis and symphalangism.

Authors:  Akira Ganaha; Tadashi Kaname; Yukinori Akazawa; Teruyuki Higa; Ayano Shinjou; Kenji Naritomi; Mikio Suzuki
Journal:  J Hum Genet       Date:  2014-11-13       Impact factor: 3.172

2.  Tarsal-carpal coalition syndrome: importance of early diagnosis.

Authors:  Gloria Tze Yan Lau; Gayatri Athalye-Jape; Natasha Amery
Journal:  BMJ Case Rep       Date:  2019-06-06

3.  A Novel GDF6 Mutation in a Family with Multiple Synostoses Syndrome without Hearing Loss.

Authors:  Ragnhild Drage Berentsen; Bjørn I Haukanes; Pétur B Júlíusson; Karen Rosendahl; Gunnar Houge
Journal:  Mol Syndromol       Date:  2018-08-15

4.  Structural biology of the TGFβ family.

Authors:  Erich J Goebel; Kaitlin N Hart; Jason C McCoy; Thomas B Thompson
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-09

5.  Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2.

Authors:  Petra Seemann; Raphaela Schwappacher; Klaus W Kjaer; Deborah Krakow; Katarina Lehmann; Katherine Dawson; Sigmar Stricker; Jens Pohl; Frank Plöger; Eike Staub; Joachim Nickel; Walter Sebald; Petra Knaus; Stefan Mundlos
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

6.  GDF5 is a second locus for multiple-synostosis syndrome.

Authors:  Katherine Dawson; Petra Seeman; Eiman Sebald; Lily King; Matthew Edwards; John Williams; Stephan Mundlos; Deborah Krakow
Journal:  Am J Hum Genet       Date:  2006-02-24       Impact factor: 11.025

7.  Brachydactyly A-1 mutations restricted to the central region of the N-terminal active fragment of Indian Hedgehog.

Authors:  Ashley M Byrnes; Lemuel Racacho; Allison Grimsey; Louanne Hudgins; Andrea C Kwan; Michel Sangalli; Alexa Kidd; Yuval Yaron; Yu-Lung Lau; Sarah M Nikkel; Dennis E Bulman
Journal:  Eur J Hum Genet       Date:  2009-03-11       Impact factor: 4.246

8.  A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN.

Authors:  K Lehmann; P Seemann; F Silan; T O Goecke; S Irgang; K W Kjaer; S Kjaergaard; M J Mahoney; S Morlot; C Reissner; B Kerr; A O M Wilkie; S Mundlos
Journal:  Am J Hum Genet       Date:  2007-06-08       Impact factor: 11.025

9.  Multiple synostoses syndrome is due to a missense mutation in exon 2 of FGF9 gene.

Authors:  Xiao-Lin Wu; Ming-Min Gu; Lei Huang; Xue-Song Liu; Hong-Xin Zhang; Xiao-Yi Ding; Jian-Qiang Xu; Bin Cui; Long Wang; Shun-Yuan Lu; Xiao-Yi Chen; Hai-Guo Zhang; Wei Huang; Wen-Tao Yuan; Jiang-Ming Yang; Qun Gu; Jian Fei; Zhu Chen; Zhi-Min Yuan; Zhu-Gang Wang
Journal:  Am J Hum Genet       Date:  2009-07       Impact factor: 11.025

10.  Mutations in the NOG gene are commonly found in congenital stapes ankylosis with symphalangism, but not in otosclerosis.

Authors:  S Usami; S Abe; S Nishio; Y Sakurai; H Kojima; T Tono; N Suzuki
Journal:  Clin Genet       Date:  2012-01-30       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.